Development of an improved live attenuated antigenic marker CSF vaccine strain candidate with an increased genetic stability
Keywords: ویروس کبد خوک; Marker vaccine; DIVA strategy; Protection; Minimal protective dose; Vaccine safety; Classical swine fever virus;